Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2025-12-28 @ 4:04 PM
Study NCT ID:
NCT03239535
Status:
UNKNOWN
Last Update Posted:
2017-08-04
First Post:
2017-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy
Sponsor:
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Organization:
Study Overview
Official Title:
Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy
Status:
UNKNOWN
Status Verified Date:
2017-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The clinical trial aims to study the safety and efficacy of adult allogeneic mesenchymal stem cells for the treatment of critical limb ischemia.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: